SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-19-010941
Filing Date
2019-04-05
Accepted
2019-04-05 17:14:57
Documents
5
Effectiveness Date
2019-04-05

Document Format Files

Seq Description Document Type Size
1 DEFA14A apvo-defa14a_20181231.htm DEFA14A 20918
2 GRAPHIC gdvd3mjrzydv000002.jpg GRAPHIC 62497
3 GRAPHIC gdvd3mjrzydv000003.jpg GRAPHIC 19233
4 GRAPHIC gdvd3mjrzydv000004.jpg GRAPHIC 10396
5 GRAPHIC gdvd3mjrzydv000001.jpg GRAPHIC 36005
  Complete submission text file 0001564590-19-010941.txt   198943
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37746 | Film No.: 19735885
SIC: 2834 Pharmaceutical Preparations